Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
92 Cards in this Set
- Front
- Back
What is cancer |
Disease characterized by a shift in control mechanisms that control proliferation and differentiation |
|
What are factors influencing cancer |
1. Gender 2. Age 3. Race 4. Genetic environmental carcinogens |
|
What are some chemical toxins that are mutagenic |
1. Azo dyes 2. Asbestos 3. Benzene |
|
What are some infection agents that cause cancer |
1. HHV-8 2. Human papilloma virus |
|
What is a sarcoma and give examples |
Cancer in connective tissue Fat, bone, muscle |
|
What is a carcinoma and give examples |
Cancer in epithelial cell Lung, breast, colon, prostate |
|
What are the stages of Tumor Progression |
1. Hyperplasia 2. Dysplasia 3. Carcinoma in situ (not cross basal lamina) 4. Cancer (Malignant tumors) - metastasis |
|
When treating the tumor what do you look at |
1. Type of tumor 2. Location and amount of disease 3. Health of patient
|
|
What are the objectives of cancer treatment |
1. Kill cancer cell 2. Lead them to apoptosis 3. Contain/limit cell growth |
|
What are some types of cancer treatments |
1. Surgery 2. Radiation 3. Chemotherapy |
|
Is mono therapy or combination therapy better for chemotherapy treatment |
Combination therapy |
|
What is the timing of chemotherapy |
Cycles = intense tx periods followed by days of no tx |
|
What is the MOA of Genotoxic Agents |
Alkylate DNA (non cell cycle dependent) |
|
What are some cell cycle dependent agents |
1. Anti-metabolites 2. Cytoskeletal inhibitors 3. Topoisomerase inhibitors |
|
When did the first drugs come out that cured cancer (which cancers) |
1960's and 1970's Leukemias and lymphomas |
|
What are the genotoxic agents |
1. Cisplatin 2. Doxorubicin 3. Cyclophosphamide |
|
What happens when you alklyate DNA |
1. Fragments DNA
2. Create inter/intra strand DNA cross link (affects DNA separation)
3. Induces mispairing of nucleotides (leads to mutation)
4. Forms DNA adducts (DNA polymerase can't work) |
|
Which genotoxic agents need to be given by IV |
1. Platinum based chemotherpeutics agents (i.e. Cisplatin) 2. Doxorubicin |
|
Which genotoxic agent can be given orally every day |
Cyclophosphamide |
|
What are the general adverse effects of genotoxic agents |
These agents affect cells that are rapidly dividing: 1. Hematopoietic effects 2. GI effects 3. Hair loss 4. Increase risk of developing cancer |
|
What are the specific adverse effects of Cisplatin, Doxorubicin, and Cyclophosphamide |
Cisplastin = renal and ototoxicity Doxorubicin = Heart effects (Heart failure) Cyclophosphamide = Bladder irration (hemorrhagic cystitis) |
|
Which of the genotoxic agents has the least adverse effects |
Cyclophosphamide |
|
Draw out the Cell Cycle |
Draw Out the Cell Cycle |
|
Where on the cell cycle do the drug work |
G1, S, G2, Mitosis (Prophase, Metaphase, Anaphase, Telophase) |
|
Which drug class works on the S phase |
Antimetabolites |
|
How do Antimetabolites work |
Similar to natural metabolites
Prevent cells from carrying out vital function and unable to grow and survive
Interfere with production of Nucleic acids, RNA, DNA |
|
What are the 3 types of Antimetabolites |
1. Folate Antagonist 2. Purine Antagonist 3. Pyrimidine Antagonist |
|
What is the Folate Antagonist |
Methotextrate |
|
What is the MOA of Methotextrate |
Inhibit dihyrdrofolate reductase (enzyme involved in forming purine and pyrimidines by allowing Carbon donation; thus no DNA replication and growth blocked) |
|
Which cancers are methotexrate used |
1. Acute lymphocytic leukemia (most common) 2. Large cell lymphoma 3. High grade lymphoma 4. Head and neck cancers 5. Breast and Bladder cancer 6. Rheumatoid arthritis |
|
What are the next generation of Antifolate |
Pemetrexed |
|
What is the MOA of Pemetrexed |
Inhibits Dihyrdofolate
Inhibits thymidylate synthase
Inhibits glycinamide ribonucelotide formyl transferase |
|
Where is Premetrexed used |
Second line therapy for non small cell lung cancer |
|
What is a problem with Antifolates |
Problems with Hematopoeitic effects |
|
What is Folinic Acid Rescue Therapy |
Give Folinic Acid with methotrexate and antifolates to decrease myelosuppression
|
|
What is the MOA of Folinic Acid |
THF analog can be used as methyl donor
DHFR insensitive
Therefore some DNA/RNA base synthesis can be carried out in normal blood and GI cells |
|
What is the function of Purine Antagonists |
Prevent continued replication of DNA and cell division |
|
What are 2 examples of Purine Antagonists |
6-Mercaptopurine 6- Thioguanine |
|
When do you used Purine Antagonists |
1. Acute lymphocytic or myelocytic leukemia 2. Lymphoblastic leukemia (kids) 3. Acute myelogenous and myelomonocytic leukemias 4. Inflammatory bowel disease 5. Organ transplant |
|
What are some ways cells can metabolize MP and TG and inactivate them |
Xanthine oxidase TPMT (Thiopurine S-Methyltransferase) |
|
What is the TPMTP Polymorphisms of Extensive, intermediate, and poor metabolizers |
wt/wt (90%) = extensive metabolizer wt/mut (10%) = intermediate metabolizer mut/mut (1/300) = poor metabolizer |
|
How do you determine TPMT Phenotype |
Metabolism of MP in blood samples then look at the metabolism/drug ratio |
|
Do poor metabolizers need more or less drugs |
Less drugs |
|
What is the MOA of Pyrimidine Antagonists |
Block synthesis of pyrimidine containing nucleotide |
|
What are the 2 Pyrimidine Antagonists |
5-Fluorouracil (5-FU) Cytarabine |
|
What is the MOA of 5-Fluorouracil |
Inhibits Thymidylate Synthase |
|
When would you use 5-FU |
Colorectal Cancer |
|
What is the drug class used in Mitosis |
Cytoskeletal inhibitors (inhibit microtubule function) |
|
What are the 2 groups of cytoskeleton and the drugs in each class |
Taxanes: 1. Paclitaxel 2. Docetaxel (anaphase)
Vinca Alkaloids 1. Vincristine 2. Vimblastin 3. Vindesine (metaphase)
|
|
When do you use Cytoskeletal Chemotherapies |
1. Breast 2. Testicular 3. Hodgkin 4. Kid leukemia 5. Rhabdomyosarcoma 6. Lung cancer 7. Neuroblastoma |
|
Which phase of the cycle do Topoisomerase I inhibitors work |
G2 Phase |
|
What is the function of Topoisomerase |
nicks DNA strands and allows the tension to relax and also reseals the DNA so replication can occur |
|
What are the 2 Topoisomerase I inhibitors |
1. Topotecan 2. Irinotecan |
|
What are the Topoisomerase II inhibitors |
1. Etoposide 2. Teniposide |
|
Which phase does Hormonal therapy work |
G1 |
|
What is the MOA of Hormonal therapy |
Starve cancer cells from hormonal signals needed for growth
Block hormones on target cell and prevent hormone production |
|
Where would you use hormonal therapy |
1. Breast 2. Ovarian 3. Prostate 4. Endometrial |
|
What are the 3 types of hormonal antagonists |
1. Selective estrogen receptor modulator (SERM) 2. Selective androgen receptor modulator (SARM) 3. Aramatase inhbitor |
|
What are the 2 types of Estrogen Receptors |
ER alpha ER beta |
|
Compare and Contrast ER alpha to ER beta |
Look at chart |
|
Which cancer does SERM target |
Breast cancer cells |
|
What is the MOA of SERM |
Changes gene expression preventing cell division |
|
What are the 3 SERM drugs |
1. Tamoxifen 2. Raloxifene 3. Toremifene |
|
How do SERMs work |
Drug goes in blocks estrogen receptor and inhibits estrogens growth stimulation effect |
|
What are the issues with Tomaxifen and its Drug Interactions |
1. Tamoxifen is a pro drug and it needs CYP2D6 to turn it into the active metabolite Endoxifen
2. CYP2D6 has variable metabolism activity (i.e. poor, moderate, extensive metabolizers)
3. Problems with Serotonin Uptake Inhibitors (Paroxetine, Fluxoetine, Bupropion) |
|
What type of metabolizer works best with Tamoxifen |
Extensive metabolizer |
|
What do Aromatase inhibitors do |
Inhibit the production of estrogen and estrodiol |
|
What are the 3 Aromatase Inhibitors |
1. Exemestane 2. Anastrozole 3. Letozole |
|
What are the SERM an Aromatase Inhibitors indications |
1. Advanced or Metastatic breast cancer 2. High risk population for invasive breast cancer |
|
What do Specific Androgen Receptor Modulators (SARM) work |
Block androgen receptors |
|
What are the 2 SARMs |
1. Flutamide 2. Bicalutamide |
|
Why does Chemotherapy Fail |
A lot of side effects
|
|
Which drug causes bone marrow depression |
Procarbazine |
|
Which drugs cause nephrotoxicity |
Platinum analog (Cisplatin, Carboplatin) Purine Antagonists (6-Mercaptopurine) |
|
Which drugs cause hepatotoxicity |
Vinca Alkaloids (Vincristine, Vinlastine) Etoposide |
|
Which drugs cause Nausea and vomiting |
Topotecan cpds |
|
Which drugs cause Alopecia |
Etoposide Vinca Alkaloids |
|
Which drugs cause Cardiotoxicity |
Anthracyclines (Doxorubicin, Daunorubicin) Herceptin |
|
Which drugs cause Hemorrhagic cystitis |
Cyclophosphamide |
|
Which Drugs cause Neuropathy |
Platinum Analogs (Cisplastin, Carboplatin) Vinca Alkaloids (Vincristine, Vinblastine) Taxol Based Chemotherapeutics |
|
What are 4 mechanisms related with Resistance and Chemotherapy |
1. Increased expression of target proteins therefore need higher amount of cancer drug, but that amount will kill all cells
2. Failure of drugs to enter cancer cell or increased rate of removal of drug from cancer cell
3. Drugs fail to reach target cell/target molecule no longer present
4. Target Molecule is Altered |
|
What causes a failure of drugs to enter cancer cells (increases efflux) |
P-Glycoprotein |
|
1. What are the Biological Response Modifiers (2) 2. What are its MOA 3. Where are they primarily used for 4. What is the route of administration 5. What are the side effects |
1.a. Interferons b. Interleukin 2 2. Modify immune system response 3. Hematopoietic neoplasias (blood cancer) 4. Parenteral routes 5. Flu-like symptoms (mild) to fever and capillary leak syndrome (Sever) |
|
What is the Monoclonal Antibody Therapy Drugs |
Rituximab Trastuzumab (herceptin) |
|
1. What is the MOA of Rituximab 2. Function 3. Side effects |
1. Binds to CD20 antigen (receptor) on the surface of B lymphocytes which activates phagocytosis and antibody dependent apoptosis
2. Inhibits proliferation of lymphocytes and lymphoma cells
3. Hypersensitivity reaction and anaphylactic shock |
|
1. What is the MOA of Trastuzumab 2. What are the side effects 3. Which patients does it work really well for |
1. Binds to epidermal growth factor receptor protein (HER2) (over expressed in some cancers like breast)
2. Allergic rxn, heart muscle damage, pulmonary toxicity
3. HER2+ metastatic breast cancer and early stage HER2+ breast cancer |
|
1. What is the Angiogenesis inhibitor 2. Which cancers is it used for 3. What is its MOA 4. What are its advantages 5. What are its disadvantages |
1. Bevacizumab (Avastin) 2. Metastatic colorectal and NSCL 3. Endothelial cell growth into the tumor 4. Fewer side effect, less chance of resistance 5. Angiogenesis is important in wound healing and normal development, long term effect no yet known
|
|
1. What are the 3 Protein Kinase Inhibitors |
1. Imatinib 2. Erlotinib 3. Ruxolitinib
|
|
1.What is the function of Imatinib 2. Which cancer is it used for |
1. Prevents phosphorylation of specific proteins involved in cell growth and differentiation
2. Chronic Myelogenous Leukemia |
|
1. What is the function of Erlotinib 2. Which cancer is it used for |
1. EGFR tyrosine kinase inhibitor 2. Lung and pancreatic cancer |
|
1. What is the function of Ruxolitinib 2. What cancer is it used for |
1. JAK-1 and JAK-2 inhibitor 2. Myelofibrosis |
|
What are the benefits of the New Generation of Chemotherapeutics |
less side effects
oral medication |